{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:33:55Z","timestamp":1793579635680,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"am","delay-in-days":283,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bone.2020.115452","type":"journal-article","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T20:56:16Z","timestamp":1590440176000},"page":"115452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Timing of anti-osteoporosis medications initiation after a hip fracture affects the risk of subsequent fracture: A nationwide cohort study"],"prefix":"10.1016","volume":"138","author":[{"given":"Chen-Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shau-Huai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Sen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2387-8508","authenticated-orcid":false,"given":"Liang-Kung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jiuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1660-9120","authenticated-orcid":false,"given":"Fei-Yuan","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2020.115452_bb0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11657-011-0060-1","article-title":"Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)","volume":"6","author":"Str\u00f6m","year":"2011","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.bone.2020.115452_bb0010","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","article-title":"An estimate of the worldwide prevalence and disability associated with osteoporotic fractures","volume":"17","author":"Johnell","year":"2006","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2020.115452_bb0015","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1136\/bmj.307.6914.1248","article-title":"Mortality and morbidity after hip fractures","volume":"307","author":"Keene","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.bone.2020.115452_bb0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.afos.2018.03.003","article-title":"An updated hip fracture projection in Asia: the Asian Federation of Osteoporosis Societies study","volume":"4","author":"Cheung","year":"2018","journal-title":"Osteoporos. Sarcopenia"},{"key":"10.1016\/j.bone.2020.115452_bb0025","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/gerona\/glt105","article-title":"Death, debility, and destitution following hip fracture","volume":"69","author":"Tajeu","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.bone.2020.115452_bb0030","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/0003-4819-152-6-201003160-00008","article-title":"Meta-analysis: excess mortality after hip fracture among older women and men","volume":"152","author":"Haentjens","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bone.2020.115452_bb0035","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1532-5415.2000.tb02647.x","article-title":"Mortality and institutionalization following hip fracture","volume":"48","author":"Cree","year":"2000","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.bone.2020.115452_bb0040","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/archinte.162.19.2217","article-title":"Undertreatment of osteoporosis in men with hip fracture","volume":"162","author":"Kiebzak","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bone.2020.115452_bb0045","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/jbmr.2218","article-title":"Secular trends in hip fractures worldwide: opposing trends east versus west","volume":"29","author":"Ballane","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115452_bb0050","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-008-0560-z","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2020.115452_bb0055","first-page":"499","article-title":"Bisphosphonates can prevent recurrent hip fracture and reduce the mortality in osteoporotic patient with hip fracture: a meta-analysis","volume":"32","author":"Peng","year":"2016","journal-title":"Pak. J. Med. Sci."},{"key":"10.1016\/j.bone.2020.115452_bb0060","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group","volume":"344","author":"McClung","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2020.115452_bb0065","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/jbmr.1625","article-title":"Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial","volume":"27","author":"Donaldson","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115452_bb0070","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2020.115452_bb0075","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.bone.2011.12.021","article-title":"Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan","volume":"50","author":"Wade","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115452_bb0080","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1359\/jbmr.090209","article-title":"Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture","volume":"24","author":"Eriksen","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115452_bb0085","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s00198-010-1473-1","article-title":"Association between timing of zoledronic acid infusion and hip fracture healing","volume":"22","author":"Col\u00f3n-Emeric","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2020.115452_bb0090","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1302\/0301-620X.94B7.29079","article-title":"Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures?","volume":"94","author":"Kim","year":"2012","journal-title":"J. Bone Joint Surg. (Br.)"},{"key":"10.1016\/j.bone.2020.115452_bb0095","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2106\/JBJS.K.01434","article-title":"Early initiation of bisphosphonate does not affect healing and outcomes of volar plate fixation of osteoporotic distal radial fractures","volume":"94","author":"Gong","year":"2012","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bone.2020.115452_bb0100","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1302\/0301-620X.95B11.31652","article-title":"Effect of early administration of alendronate after surgery for distal radial fragility fracture on radiological fracture healing time","volume":"95\u2013B","author":"Uchiyama","year":"2013","journal-title":"Bone Joint J."},{"key":"10.1016\/j.bone.2020.115452_bb0105","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00198-014-2903-2","article-title":"Timing of the initiation of bisphosphonates after surgery for fracture healing: a systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Li","year":"2015","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2020.115452_bb0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11657-017-0321-8","article-title":"Effect of bisphosphonate initiation at week 2 versus week 12 on short-term functional recovery after femoral neck fracture: a randomized controlled trial","volume":"12","author":"Unnanuntana","year":"2017","journal-title":"Arch. Osteoporos."},{"issue":"12","key":"10.1016\/j.bone.2020.115452_bb0115","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/j.injury.2017.10.026","article-title":"Evaluation of mandibular fracture healing in rats under zoledronate therapy: a histologic study","volume":"48","author":"Zandi","year":"2017","journal-title":"Injury"},{"key":"10.1016\/j.bone.2020.115452_bb0120","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00701-012-1283-7","article-title":"The relation between zoledronic acid infusion and interbody fusion in patients undergoing transforaminal lumbar interbody fusion surgery","volume":"154","author":"Li","year":"2012","journal-title":"Acta Neurochir."},{"key":"10.1016\/j.bone.2020.115452_bb0125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10195-010-0083-1","article-title":"The effect of zoledronate during bone healing","volume":"11","author":"Matos","year":"2010","journal-title":"J. Orthop. Traumatol."},{"key":"10.1016\/j.bone.2020.115452_bb0130","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00198-008-0767-z","article-title":"Effect of alendronate in elderly patients after low trauma hip fracture repair","volume":"20","author":"Cecilia","year":"2009","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2020.115452_bb0135","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00198-011-1556-7","article-title":"Beneficial effect of risedronate for preventing recurrent hip fracture in the elderly Japanese women","volume":"23","author":"Osaki","year":"2012","journal-title":"Osteoporos. Int."},{"issue":"10","key":"10.1016\/j.bone.2020.115452_bb0140","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13246","article-title":"Visualisation of the unmet treatment need of osteoporotic fracture in Taiwan: a nationwide cohort study","volume":"72","author":"Wang","year":"2018","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.bone.2020.115452_bb0145","first-page":"99","article-title":"Using Taiwan\u2019s National Health Insurance Research databases for pharmacoepidemiology research","volume":"15","author":"Hsiao","year":"2007","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.bone.2020.115452_bb0150","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2165\/00003088-200544060-00001","article-title":"Pharmacokinetics\/pharmacodynamics of bisphosphonates: use for optimisation of intermittent therapy for osteoporosis","volume":"44","author":"Cremers","year":"2005","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bone.2020.115452_bb0155","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2147\/PPA.S40736","article-title":"Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis","volume":"7","author":"Kozma","year":"2013","journal-title":"Patient Prefer. Adherence"},{"issue":"2 Suppl","key":"10.1016\/j.bone.2020.115452_bb0160","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.12.002","article-title":"Impact of osteoporosis treatment adherence on fracture rates in North America and Europe","volume":"122","author":"Siris","year":"2009","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bone.2020.115452_bb0165","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/aje\/kwi307","article-title":"Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods","volume":"162","author":"Zhou","year":"2005","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.bone.2020.115452_bb0170","doi-asserted-by":"crossref","first-page":"b5087","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes","volume":"340","author":"L\u00e9vesque","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.bone.2020.115452_bb0175","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pds.1200","article-title":"Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics","volume":"15","author":"Schneeweiss","year":"2006","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.bone.2020.115452_bb0180","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11192-010-0289-2","article-title":"Taiwan\u2019s National Health Insurance Research Database: administrative health care database as study object in bibliometrics","volume":"86","author":"Chen","year":"2010","journal-title":"Scientometrics"},{"key":"10.1016\/j.bone.2020.115452_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112257","article-title":"Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan","volume":"9","author":"Wu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2020.115452_bb0190","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jclinepi.2009.01.016","article-title":"Agreement between self-reported and health insurance claims on utilization of health care: a population study","volume":"62","author":"Yu","year":"2009","journal-title":"J. Clin. Epidemiol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220302325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220302325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:49:15Z","timestamp":1757612955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328220302325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":38,"alternative-id":["S8756328220302325"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115452","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Timing of anti-osteoporosis medications initiation after a hip fracture affects the risk of subsequent fracture: A nationwide cohort study","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115452"}}